Summary
Overview
Work History
Education
Skills
Timeline
Generic

Neda Ebrahimi

Vaughan,ON

Summary

Articulate professional with substantial experience in leading research and supporting students. Skilled in all aspects of clinical research study design, implementation and dissemination. Extensive knowledge of regulatory process, inter-institutional and Health Canada approvals, and all other monitoring aspects. Possesses versatile skills in project management, problem-solving, and collaboration. Brings fresh perspective and strong commitment to quality and success. Recognized for adaptability and proactive approach in delivering effective solutions. Proactive and goal-oriented professional with excellent time management and problem-solving skills. Known for reliability and adaptability, with swift capacity to learn and apply new skills. Committed to leveraging these qualities to drive team success and contribute to organizational growth.

Overview

17
17
years of professional experience

Work History

Postdoctoral Fellow

Sunnybrook Health Sciences
05.2024 - Current
  • Oversee execution and conduct of GutPDA- A feasibility pilot trial designed to investigate implementation of dietary and supplemental interventions targeting gut microbiome, in pregnant women at high risk of Perinatal Depression and Anxiety (PDA)
  • Collaborated with colleagues to gather research and publish findings.
  • Secured grant funding for research projects through the development of compelling proposals and presentations.
  • Established partnerships with industry leaders to facilitate technology transfer and commercialization efforts.
  • Conducted independent research within hospital and academic environments.
  • Conducted comprehensive literature reviews to inform experimental design and theoretical frameworks.

Principal Investigator

Canadian College of Naturopathic Medicine
04.2024 - Current
  • Primary investigator in a feasibility trial: targeting maternal gut microbiome to improve mental health outcomes
  • Oversee all administrative, budgetary, regulatory, and proper conduct of study related activities
  • Managed budgets effectively, allocating resources strategically to maximize return on investment for all stakeholders involved in research endeavors.
  • Streamlined processes for data management, reducing time spent on administrative tasks and increasing focus on research activities.
  • Enhanced public understanding of critical issues by translating complex scientific findings into accessible language for non-experts audiences through various media channels.
  • Negotiated contracts with external vendors ensuring cost-effective solutions while maintaining high standards in research materials and services.
  • Training & mentoring all CCNM and University of Toronto students on projects related to maternal microbiome and health

Head of Microbiome Research Department

Canadian College of Naturopathic Medicine
01.2019 - 03.2024
  • Build and led the Microbiome Research Branch at CCNM
  • Responsible for construct and execution of clinical research, knowledge translation and dissemination
  • Build and expand network of scientific collaborators and partners
  • Academic mentorship of student research activities- (Mentorship of 16 students to date)
  • Secure Funding to support ongoing research at CCNM
  • Design the first feasibility trial of maternal gut & mental health in collaboration with Sunnybrook Hospital
  • Worked well in a team setting, providing support and guidance.
  • Resolved problems, improved operations and provided exceptional service.
  • Demonstrated strong organizational and time management skills while managing multiple projects.

Clinical Research Project Coordinator

SickKids Hospital-Dept. Neurosci. & Mental Health
09.2017 - 01.2019
  • Company Overview: Mental Health and Neurosciences Department
  • Oversee study execution in largest of 23 centers for national prospective longitudinal study examining clinical outcomes in more than 200 children with demyelination
  • Significantly increased study enrollment of controls (30%)
  • Reduced patient withdrawal (95% retention rate)
  • Identified barriers leading to rejection of certain study components (i.e Stool sample collection) by encouraging participation and removing some barriers
  • Identified areas for improvement within existing research protocols, resulting in enhanced overall project outcomes. Re-strategized transfer and delivery to collaborating centers, of collected study material (MRI Scans, accelerometer files, biological samples, etc.), leading to 60% faster and more reliable delivery
  • Maintained comprehensive documentation of project activities to ensure compliance with ethical guidelines and institutional requirements.
  • Reduced data entry errors by implementing rigorous quality control measures throughout the research process.Redesigned participant log sheets and reformatted electronic databases to more practical and manageable state improving accessibility to other research team members and reducing data loss

Drug Information Specialist

SickKids Hospital-Motherisk
01.2008 - 05.2017
  • Critically appraised published research studies for validity, reliability, applicability, relevance, thus informing decision-making by patients and healthcare providers
  • Disseminating knowledge from all published studies regarding maternal exposure during pregnancy/breastfeeding to a specific drug (i.e. SSRI) and the corresponding impact on the fetus/newborn to mothers and HCP
  • Improved healthcare professionals'' understanding of medications through timely and precise communication.
  • Presented at national conferences or seminars on topics pertinent to drug information and medication safety.
  • Consistently recognized as one of the top counselors by management
  • Familiarity with many therapeutic drugs, supplements, infections, and related comorbidities
  • Participated in multidisciplinary team meetings to discuss complex cases involving medication therapy management. (i.e. polytherapy, teratogenic drugs, new therapies, etc.)
  • Advised patients on medication side effects and contraindications and explained proper administration.

Pregnancy Registry Manager

SickKids Hospital-Dept. Clinical Pharm. &Toxicol.
01.2011 - 03.2015
  • Company Overview: Clinical Pharmacology and Toxicology Department
  • In collaboration with Novartis Pharmaceuticals, established a prospective pregnancy registry to compare
  • Pregnancy, neonatal and disease outcomes in women with Relapsing Remitting Multiple Sclerosis (RRMS) treated with Gilenya (fingolimod) to ones treated with other Immunomodulatory drugs
  • Screened over 400 women with RRMS diagnosis and recruited over 200 meeting study criteria
  • Regular and timely follow-up of subjects over a 25-month period
  • Responsible for developing case report forms (CRFs), electronic databases and timely collection of several hundred data points
  • Coding, analysis, reporting of data and publishing multiple studies in peer review journals
  • More than 10 presentations at seminars, scientific conferences and departmental meetings to scientists and HCPs

Clinical Research Coordinator

SickKids Hospital-Dept. Clinical Pharm. &Toxicol.
09.2008 - 06.2011
  • Conducted a clinical study assessing the effectiveness and neonatal safety of Proctofoam HC for the treatment of hemorrhoids/anal fissures in pregnancy
  • Screening, recruitment, and follow-up of 200+ women with ano-rectal symptoms in the third trimester of pregnancy
  • Evaluated changes in symptoms, pregnancy and neonatal outcomes following usage of medication
  • Developed and validated a new clinical scale to assess symptom severity before and after treatment- Colorectal Evaluation of Clinical Therapeutics Scale (CORECTS)
  • Followed clinical research protocols and conducted study visits in compliance with ICH/GCP and FDA regulations.

Clinical Counselor NVP Line

SickKids Hospital
01.2010 - 01.2011
  • Providing evidence-based medical information to pregnant women with severe nausea and vomiting of pregnancy (NVP) for management of symptoms using lifestyle, dietary, and pharmacological interventions
  • Developed and validated a clinical scale, Pregnancy Unique Quantification of Emesis in 24 hours (PUQE- 24), to assess NVP severity (published in JOGC with 70+ citations to date)
  • Weekly follow-up of patients using PUQE-24 to monitor well-being and provide strategies to improve outcomes
  • Published a systematic review on Optimal Management of Nausea Vomiting of Pregnancy (100+ citations to date)

Education

Ph.D. - Pharmaceutical Sciences (Clinical Pharmacology)

University of Toronto
Toronto, Ontario
06.2018

Master of Science - Pharmaceutical Sciences (Clinical Pharmacology)

University of Toronto
Toronto, Ontario
06.2011

Bachelor of Science - Medical Sciences & Pharmacology & Toxicology

University of Western Ontario
London, ON
06.2007

Skills

  • Project management
  • Interdisciplinary collaboration
  • Team building
  • Interpersonal & Analytical skills
  • Scientific communication/Presentation
  • Literature review & Research proposals
  • Medical Writing
  • Familiarity with many therapeutic areas

Timeline

Postdoctoral Fellow

Sunnybrook Health Sciences
05.2024 - Current

Principal Investigator

Canadian College of Naturopathic Medicine
04.2024 - Current

Head of Microbiome Research Department

Canadian College of Naturopathic Medicine
01.2019 - 03.2024

Clinical Research Project Coordinator

SickKids Hospital-Dept. Neurosci. & Mental Health
09.2017 - 01.2019

Pregnancy Registry Manager

SickKids Hospital-Dept. Clinical Pharm. &Toxicol.
01.2011 - 03.2015

Clinical Counselor NVP Line

SickKids Hospital
01.2010 - 01.2011

Clinical Research Coordinator

SickKids Hospital-Dept. Clinical Pharm. &Toxicol.
09.2008 - 06.2011

Drug Information Specialist

SickKids Hospital-Motherisk
01.2008 - 05.2017

Ph.D. - Pharmaceutical Sciences (Clinical Pharmacology)

University of Toronto

Master of Science - Pharmaceutical Sciences (Clinical Pharmacology)

University of Toronto

Bachelor of Science - Medical Sciences & Pharmacology & Toxicology

University of Western Ontario
Neda Ebrahimi